BACKGROUND: The Raymond-Roy Occlusion Classification (RROC) is the standard for evaluating coiled aneurysms (Class I: complete obliteration; Class II: residual neck; Class III: residual aneurysm), but not all Class III aneurysms behave the same over time. METHODS: This is a retrospective review of 370 patients with 390 intracranial aneurysms treated with coil embolization. A Modified Raymond-Roy Classification (MRRC), in which Class IIIa designates contrast within the coil interstices and Class IIIb contrast along the aneurysm wall, was applied retrospectively. RESULTS: Class IIIa aneurysms were more likely to improve to Class I or II than Class IIIb aneurysms (83.34% vs 14.89%, p<0.001) and were also more likely than Class II to improve to Class I (52.78% vs 16.90%, p<0.001). Class IIIb aneurysms were more likely to remain incompletely occluded than Class IIIa aneurysms (85.11% vs 16.67%, p<0.001). Class IIIb aneurysms were larger with wider necks while Class IIIa aneurysms had higher packing density. Class IIIb aneurysms had a higher retreatment rate (33.87% vs 6.54%, p<0.001) and a trend toward higher subsequent rupture rate (3.23% vs 0.00%, p=0.068). CONCLUSIONS: We propose the MRRC to further differentiate Class III aneurysms into those likely to progress to complete occlusion and those likely to remain incompletely occluded or to worsen. The MRRC has the potential to expand the definition of adequate coil embolization, possibly decrease procedural risk, and help endovascular neurosurgeons predict which patients need closer angiographic follow-up. These findings need to be validated in a prospective study with independent blinded angiographic grading. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
BACKGROUND: The Raymond-Roy Occlusion Classification (RROC) is the standard for evaluating coiled aneurysms (Class I: complete obliteration; Class II: residual neck; Class III: residual aneurysm), but not all Class III aneurysms behave the same over time. METHODS: This is a retrospective review of 370 patients with 390 intracranial aneurysms treated with coil embolization. A Modified Raymond-Roy Classification (MRRC), in which Class IIIa designates contrast within the coil interstices and Class IIIb contrast along the aneurysm wall, was applied retrospectively. RESULTS:Class IIIa aneurysms were more likely to improve to Class I or II than Class IIIb aneurysms (83.34% vs 14.89%, p<0.001) and were also more likely than Class II to improve to Class I (52.78% vs 16.90%, p<0.001). Class IIIb aneurysms were more likely to remain incompletely occluded than Class IIIa aneurysms (85.11% vs 16.67%, p<0.001). Class IIIb aneurysms were larger with wider necks while Class IIIa aneurysms had higher packing density. Class IIIb aneurysms had a higher retreatment rate (33.87% vs 6.54%, p<0.001) and a trend toward higher subsequent rupture rate (3.23% vs 0.00%, p=0.068). CONCLUSIONS: We propose the MRRC to further differentiate Class III aneurysms into those likely to progress to complete occlusion and those likely to remain incompletely occluded or to worsen. The MRRC has the potential to expand the definition of adequate coil embolization, possibly decrease procedural risk, and help endovascular neurosurgeons predict which patients need closer angiographic follow-up. These findings need to be validated in a prospective study with independent blinded angiographic grading. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Thomas W Link; Srikanth R Boddu; Hoda T Hammad; Jared Knopman; Ning Lin; Pierre Gobin; Athos Patsalides Journal: Interv Neuroradiol Date: 2017-10-31 Impact factor: 1.610
Authors: Mirja M Wirtz; Clemens M Schirmer; Oded Goren; Christian O Bohan; Shamsher Dalal; Gregory Weiner; Paul M Foreman; Christoph J Griessenauer Journal: Interv Neuroradiol Date: 2019-12-19 Impact factor: 1.610
Authors: Christopher J Stapleton; Jay I Kumar; Brian P Walcott; Collin M Torok; Pankaj K Agarwalla; Matthew J Koch; Aman B Patel Journal: Interv Neuroradiol Date: 2016-02-27 Impact factor: 1.610
Authors: J-K Burkhardt; V Srinivasan; A Srivatsan; F Albuquerque; A F Ducruet; B Hendricks; B A Gross; B T Jankowitz; A J Thomas; C S Ogilvy; G A Maragkos; A Enriquez-Marulanda; R W Crowley; M R Levitt; L J Kim; C J Griessenauer; C M Schirmer; S Dalal; K Piper; M Mokin; E A Winkler; A A Abla; C McDougall; L Birnbaum; J Mascitelli; M Litao; O Tanweer; H Riina; J Johnson; S Chen; P Kan Journal: AJNR Am J Neuroradiol Date: 2020-05-28 Impact factor: 3.825